Purity
99%
Origin
USA Licensed Pharmacy
This compound is provided for laboratory research purposes only. It is not intended for human or veterinary use, and no therapeutic or diagnostic claims are made.
METABOLIC
Retatrutide
Triple-receptor agonist (GLP-1, GIP, glucagon) under active clinical investigation for metabolic research. BDR is one of only 3 licensed compounding pharmacies in the USA cleared to manufacture this compound.
Select Size
$230 CAD
1–3 business days estimated delivery across Canada
Free shipping on orders over $300 CAD
For qualified research institutions only. Contact us to discuss bulk pricing.
Areas of Research Interest
Investigated as a triple agonist at GLP-1, GIP, and glucagon receptors simultaneously
Studied for metabolic regulation and energy homeostasis in preclinical models
Explored for effects on adipogenesis, lipid metabolism, and body composition
Researched for glucose homeostasis and insulin sensitivity pathways
Under active Phase 3 clinical investigation for obesity and metabolic syndrome protocols
Storage and Handling
Store lyophilized powder at -20°C until use
Once reconstituted, store at 2-8°C and use within 28 days
Handle under aseptic conditions; cold-chain shipping required
Avoid repeated freeze-thaw cycles
Pairs Well With
Retatrutide
$230 CAD/vial